Difference between revisions of "Interferon gamma-1b (Actimmune)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) |
|||
| Line 11: | Line 11: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
* 2/25/1999: Initial FDA approval | * 2/25/1999: Initial FDA approval | ||
| + | |||
| + | == Patient Drug Information== | ||
| + | *[https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf Interferon gamma-1b (Actimmune) Package Insert]<ref>[https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf Interferon gamma-1b (Actimmune) Package Insert]</ref> | ||
==Also known as== | ==Also known as== | ||
*'''Brand name:''' Actimmune | *'''Brand name:''' Actimmune | ||
| + | |||
| + | ==References== | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 11:23, 4 April 2021
General information
Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways.
Route: SC
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.
Diseases for which it was used
History of changes in FDA indication
- 2/25/1999: Initial FDA approval
Patient Drug Information
Also known as
- Brand name: Actimmune